OUR FUNDS
The portfolio companies at the heart of our Growth Capital Fund and Innovation Fund share a commitment to driving meaningful change across the sector, catalyzing advances in diagnosis and treatment to improve patient care, and reducing the rising costs of healthcare delivery.
seeks to deploy between
$10-25MM
into companies that have removed essentially all development and regulatory risk and are entering a growth phase that will lead to successful exit within 3 years.
Our Growth Capital Fund invests in companies with completed or substantially completed development and regulatory programs that are at the cusp of meaningful final proof of commercial concept or commercial growth. The companies will demonstrate differentiated innovation, creating meaningful clinical contributions to healthcare quality and outcomes, cost-effective solutions for providers, payers, and patients, and rewarding exit and investment returns within 36 months of investment. The target investment for BioVentures MedTech Growth Capital Fund is $10-25MM with opportunities for syndication and LP co-investment depending on rational use of proceeds and capital needs.
seeks to deploy between
$5-10MM
often in multiple tranches/rounds into companies
that are in development phase with anticipated
exits within 4-6 years.
Our Innovation Fund will invest in companies at an earlier stage, but that still possess the attributes of novel applications and breakthrough technologies aimed at improving health for patients, creating ease of implementation for physicians, and reducing delivery costs for hospitals and healthcare systems. The Innovation Fund is designed to invest in game-changing technologies across the MedTech spectrum that require capital, time, and expertise to de-risk each stage of development before reaching market or exit. The target investment for BioVentures MedTech Innovation Fund is $5-10MM typically spread over multiple tranches/rounds and may also offer opportunities for syndication and LP co-investment depending on rational use of proceeds and capital needs.